HYPD

HYPERION DEFI INC

HYPD·30234E203·US·Common Stock·Healthcare - Biotechnology-Activist

HYPD (HYPERION DEFI INC) is held by 19 institutional investors as of Q1 2026. Largest holders: MORGAN STANLEY ($821,051), JANE STREET GROUP, LLC ($442,566), RENAISSANCE TECHNOLOGIES LLC ($398,961). Net institutional sentiment: Mixed.

19
Holders
Avg rating(4 Elite)
$3.2M
Total Value
55% (20)
Fund Consensus
6 buying - 5 selling
HYPDSmart Money Verdict
View all
Held by 19 funds
4 elite
Who's Trading
ActivistFAForsakringsaktiebolaget Avanza Pension8.6%Jul 1, 2026
ActivistFAForsakringsaktiebolaget Avanza Pension9.9%Apr 1, 2026
InsiderSRStrahlman Ellen RBuy $44KDec 29, 2025
InsiderSRStrahlman Ellen RBuy $43KDec 29, 2025
InsiderSRStrahlman Ellen RBuy $14KDec 26, 2025
InsiderSRStrahlman Ellen RBuy $13KDec 26, 2025
InsiderSRStrahlman Ellen RBuy $62KDec 18, 2025
InsiderSRStrahlman Ellen RBuy $59KDec 18, 2025
InsiderWDWalters Happy DavidBuy $187KDec 17, 2025
InsiderGSGELTZEILER MICHAEL SBuy $90KDec 17, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
237,986(+567x)$821,0510.0%+2.21%
27
Decreased
128,280(-7.3%)$442,5660.0%-8.31%
0
Decreased
115,641(-37.9%)$398,9610.0%-8.31%
0
Increased
112,906(+563.2%)$389,5260.0%+0.84%
38
Increased
81,108(+3.8%)$279,8230.0%-68.62%
16
Increased
77,080(+28.1%)$265,9750.0%-55.12%
20
Decreased
48,790(-45.5%)$168,3260.0%-8.71%
0
Unchanged
25,857$89,2070.0%-69.82%
0
New
25,575$88,2340.0%+2.66%
30
Unchanged
20,500$71,0000.0%-8.31%
0
Unchanged
18,731$64,6220.0%-62.72%
0
Unchanged
10,800$37,2600.0%-8.31%
0
New
10,395$35,8630.0%+2.66%
30
Unchanged
105$3430.0%-69.82%
0
Unchanged
54$1860.0%-62.39%
0
Unchanged
30$1040.0%-71.41%
0
Unchanged
8$260.0%+173.45%
0
Unchanged
1$30.0%+173.45%
0
Decreased
6(-99.4%)$00.0%-8.31%
0
Exited
0(-100.0%)$35,7890.0%-70.59%
0

Showing 1-20 of 20

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used